301017 Shu Yu Civilian Pharmacy Corp.,Ltd.
- 11.30
- -0.55-4.64%
Shu Yu Civilian Pharmacy Corp.,Ltd. News
Shuyu Pingmin: Announcement on the conversion of convertible corporate bonds to shares in the third quarter of 2024
Shuyu Pingmin: Progress Announcement on Providing Guarantees for Holding Subsidiaries
Shuyu Pingmin: Announcement of Resolutions of the 36th Meeting of the Third Board of Directors
Shuyu Pingmin: Announcement of Resolutions of the 24th Meeting of the Third Board of Supervisors
Shuyu Civic: Announcement on the estimated amount of foreign donations in 2024
Shuyu Pingmin: Announcement on pre-disclosure of shareholders holding 5% or more of shares to reduce their holdings
Shuyu Pingmin: Announcement on the cancellation of the pledge of some of the shares of the controlling shareholder and actual controller
Shuyu Pingmin: Announcement on Changing the Representative for Continued Supervision and Sponsorship
Shuyu Pingmin: Announcement on not revising Shuyu\'s debt-for-equity conversion price downward
Shuyu Pingmin: Announcement of Resolutions of the 35th Meeting of the Third Board of Directors
Shuyu Pingmin: Dongxing Securities Co., Ltd.\'s 2024 Semi-Annual Continuous Supervision and Follow-up Report on Shuyu Civilian Pharmacy Chain Co., Ltd.
Shuyu Pingmin: Announcement on Abnormal Fluctuations in Stock Trading
Shuyu Civic: 301017 Shuyu Civic Investor Relations Management Information 20240830
Shuyu Civic: Announcement on preparations for asset impairment for the semi-annual calculation of 2024
Shuyu Civic: Semi-Annual Report 2024
Shuyu Pingmin: An indicative announcement on the conditions expected to trigger a downward revision of the convertible debt-for-equity conversion price
Shuyu Pingmin: Summary table on the use of non-operating capital and other related capital transactions for the first half year of 2024
Shuyu Civic: Summary of the 2024 Semi-Annual Report
Shuyu Pingmin: Announcement on changes in accounting policies
Shuyu Civic: Special Report on the Storage and Use of Funds Raised for the Semi-Annual Year 2024
Analysis
Price Target
No Data
No Data